Gyon Technologies Capital Management’s Novartis NVS Stock Holding History

Gyon Technologies Capital Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,699	Closed	-$676K	–	539
2022 Q1	$676K	Buy	+7,699	New	+$667K	0.48%	64
2021 Q2	–	Sell	-5,532	Closed	-$473K	–	457
2021 Q1	$473K	Buy	5,532 +3,233	+141%	+$290K	0.21%	172
2020 Q4	$217K	Buy	+2,299	New	+$201K	0.07%	300

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Gyon Technologies Capital Management's NVS Position: Q2 2022 in Review

Gyon Technologies Capital Management sold out of Novartis (NVS) in Q2 2022, closing a stake of 7,699 shares — an estimated $676K sold.

Gyon Technologies Capital Management first reported a position in NVS in Q4 2020 and held it in 3 quarters. The position peaked at $676K in Q1 2022. 1,140 funds tracked by Wall St. Rank hold NVS as of Q2 2022.

Gyon Technologies Capital Management reported no remaining Novartis position as of Q2 2022 after selling out during the quarter.
Gyon Technologies Capital Management sold 7,699 Novartis shares in Q2 2022, an estimated $676K.
Gyon Technologies Capital Management first reported a position in Novartis in Q4 2020 and held it in 3 quarters.
Gyon Technologies Capital Management's Novartis position peaked at $676K in Q1 2022.
1,140 funds tracked by Wall St. Rank held Novartis as of Q2 2022.

Based on Gyon Technologies Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.